Identification of Gene-based Potential Biomarkers for Cephalexin-induced Nephrotoxicity in Mice

  • Park, Han-Jin (Toxicogenomics Team, Korea Institute of Toxicology) ;
  • Oh, Jung-Hwa (Toxicogenomics Team, Korea Institute of Toxicology) ;
  • Hwang, Ji-Yoon (Toxicogenomics Team, Korea Institute of Toxicology) ;
  • Lim, Jung-Sun (Toxicogenomics Team, Korea Institute of Toxicology) ;
  • Jeong, Sun-Young (Toxicogenomics Team, Korea Institute of Toxicology) ;
  • Kim, Yong-Bum (Clinical Pathology Team, Korea Institute of Toxicology) ;
  • Yoon, Seok-Joo (Toxicogenomics Team, Korea Institute of Toxicology)
  • Published : 2006.09.30

Abstract

Cephalexin, one of most widely prescribed cephalosporin, has been reported to cause acute renal failure as a side effect in human and experimental animals. Although numerous animal studies have been reported for the cephalosporin nephrotoxicity, the molecular and cellular nephrotoxic mechanisms of cephalexin are still unknown. This investigation evaluated the time-dependent gene expression profile of kidney in mouse during cephalexin induced nephrotoxicity. C57BL/6 female mice were administered either saline or 1,000 mg/kg cephalexin intraperitoneally. Mice were sacrificed at 3, 6, and 24 hr after administration. Blood biochemical and histopathological results indicated cephalexin induced nephrotoxicity. Microarray experiment carried out using Affymetrix $GeneChip^{(R)}$. There were 198 informative genes that were significantly expressed >5-fold versus control at 3, 6, and 24 hr (p<0.01), of which 156 and 42 were up-and down-regulated, respectively. Major classes of up-regulated genes at 3, 6 hr included those involved in MAPK/Jak-STAT signaling pathway and immune response such as cytokine-cytokine receptor interaction and complement and coagulation cascades. At 24 hr, up-regulated genes were mainly involved in regeneration/repair and immune response; down-regulated genes were generally associated with transporters and intermediary metabolism. Among the up-regulated genes at 24 hr, several potential biomarkers on nephrotoxicity such as Kim-1, Fga, Timp1, and Slc34a2 were clustered in a same category. In addition, Tnfrsf12a and Lcn2 which were consistently up-regulated (>5 fold) were also included as potential biomarkers. These results may provide clues for elucidating the mechanism of cephalexin induced nephrotoxicity and evaluating potential biomarkers to assess nephrotoxicity.

Keywords

References

  1. Nishimura, H. et al. Experimental evaluation of a new antibiotic, Cephalexin (Lilly), a derivative of cephalosporin C. 1. Antimicrobial action in vitro and in vivo and organ distribution following oral administration in mice. Saishin Igaku. 24(8), 1756-1766 (1969)
  2. Gentry, L.O. Cephalosporins in urinary tract infection. Drugs 34(2), 154-163(1987)
  3. Barza, M. The nephrotoxicity of cephalosporins: An overview. J Infect Dis. 137, 60-73(1978) https://doi.org/10.1093/infdis/137.Supplement.S60
  4. Tune, B.M. Renal tubular transport and nephrotoxicity of ${\beta}$-lactam antibiotics: structure-activity relationships. Minor Electrolyte Metab. 20(4), 221-231 (1994)
  5. Tune, B.M. et al. Cephalosporin and Carbacephem nephrotoxicity. Biochem. Phamarcol. 51(4), 557-561 (1996) https://doi.org/10.1016/0006-2952(95)02237-6
  6. Burczynski, M.E. et al. Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells. Toxicol. Sci. 58(2), 399-415 (2000) https://doi.org/10.1093/toxsci/58.2.399
  7. Hamadeh, H.K. et al. Gene expression analysis reveals chemical-specific profiles. Toxicol. Sci. 67(2), 219-231 (2002) https://doi.org/10.1093/toxsci/67.2.219
  8. Afshari, C.A. et al. Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation. Cancer Res. 59(19), 4759-4760 (1999)
  9. Tennant, R.W. The National Center for Toxicogenomics: using new technologies to inform mechanistic toxicology. Environ. Health Perspect. 110(1), A8-A10 (2002) https://doi.org/10.1289/ehp.110-a8
  10. Bulera, S.J. et al. RNA expression in the early characterization of hepatotoxicants in Wistar rats by highdensity DNA microarrays. Hepatology 33(5), 1239-1258 (2001) https://doi.org/10.1053/jhep.2001.23560
  11. Lettieri, T. Recent Applications of DNA microarray technology to toxicology and ecotoxicology. Environ. Health Perspect. 114(1), 4-9 (2006)
  12. Tune, B.M. The nephrotoxicity of cephalosporin antibiotics. Structure-activity relationships. Comments Toxicol. 1, 145-170 (1986)
  13. Eisen, M.B. et al. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U S A. 95(25), 14863-14868 (1998)
  14. Goldstein, R.S. et al. Biochemical mechanisms of cephaloridine nephrotoxiciy. Life Sci. 42(19), 1809- 1816 (1988) https://doi.org/10.1016/0024-3205(88)90018-5
  15. Duarte, C.G. & Preuss, H.G. Assessment of renal function glomerular and tubular. Clin. Lab. Med. 13 (1), 33-52 (1993)
  16. Morey, M.S. et al. Modulation of the Ras/MAPK signaling pathway by the redoxfunction of selenoproteins in Drosophila melanogaster. Develop. Biol. 238 (1), 145-156 (2001) https://doi.org/10.1006/dbio.2001.0389
  17. Nishiyama, A. & Abe, Y. Molecular Mechanisms and Therapeutic Strategies of Chronic Renal Injury: Renoprotective Effects of Aldosterone Blockade. J. Pharmacol. Sci. 100(1), 9-16 (2006) https://doi.org/10.1254/jphs.FMJ05003X3
  18. Wu, Y.J. et al. The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway. J. Pharmacol. Exp. Ther. 312(2), 424-431 (2005) https://doi.org/10.1124/jpet.104.075119
  19. Gao, B. STATs and liver disease. Cell Mol. Immunol. 2(2), 92-100 (2005)
  20. Vaidya, V.S. et al. Role of tissue repair in survival from s-(1, 2-dichlorovinyl)-L-cysteine-induced acute renal tubular necrosis in the mouse. Toxicol. Sci. 74 (1), 215-27 (2003) https://doi.org/10.1093/toxsci/kfg111
  21. Kharasch, E.D. et al. Gene expression profiling of nephrotoxicity from the sevoflurane degradation product fluoromethyl-2, 2-difluoro-1-(trifluoromethyl) vinyl ether ('compound A') in rats. Toxicol. Sci. 90(2), 419-431 (2006) https://doi.org/10.1093/toxsci/kfj088
  22. Amin, R.P. et al. Identification of putative gene based markers of renal toxicity. Environ. Health Perspect. 112(4), 465-479 (2004) https://doi.org/10.1289/ehp.6683
  23. Davis, J.W. 2nd et al. Quantitative gene expression analysis in a nonhuman primate model of antibioticinduced nephrotoxicity. Toxicol. Appl. Pharmacol. 200(1), 16-26 (2004) https://doi.org/10.1016/j.taap.2004.02.001
  24. Thukral, S.K. et al. Prediction of nephrotoxicant action and identification of candidate toxicity-related biomarkers. Toxicol. Pathol. 33(3), 343-55 (2005) https://doi.org/10.1080/01926230590927230
  25. Han, W.K. et al. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 62(1), 237-244 (2002) https://doi.org/10.1046/j.1523-1755.2002.00433.x
  26. Ichimura, T. et al. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am. J. Physiol. Renal Physiol. 286(3), 552-563(2004) https://doi.org/10.1152/ajprenal.00285.2002
  27. You, G. The role of organic ion transporters in drug disposition: an update. Curr Drug. Metab. 5(1), 55-62 (2004) https://doi.org/10.2174/1389200043489207